HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients.

Abstract
As a partial test of whether the same or different patients benefit from cognitive therapy and tricyclic antidepressant agents, depressed outpatients first received cognitive therapy, then nonresponders were treated with either imipramine or placebo. If the two treatments were effective for the same subgroup of patients, imipramine should not be more effective than placebo because potential responders should already have been removed by treatment with cognitive therapy. Alternatively, if cognitive therapy and imipramine are effective for different subtypes of depressive disorder, then imipramine ought to be more effective than placebo for patients failing to benefit from cognitive therapy because some potential imipramine failures would already have been removed. Thirty-six depressed outpatients were treated with weekly cognitive therapy for 16 weeks with 17 (47%) responding. Nonresponders were then randomly assigned to imipramine or placebo for 6 weeks to a maximum dose of 300 mg of imipramine per day. Of 12 patients completing the double-blind medication trial, all 5 assigned to imipramine had a clear-cut response, whereas none of the other seven benefited from placebo (chi 2 = 12.00; p = 0.001). Although the numbers are small, these results suggest rejection of the hypothesis that imipramine is effective for the same subpopulation of depressed patients as is cognitive therapy.
AuthorsJ W Stewart, M A Mercier, V Agosti, M Guardino, F M Quitkin
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 13 Issue 2 Pg. 114-9 (Apr 1993) ISSN: 0271-0749 [Print] United States
PMID8463443 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Imipramine
Topics
  • Adult
  • Ambulatory Care
  • Cognitive Behavioral Therapy
  • Combined Modality Therapy
  • Depressive Disorder (drug therapy, psychology)
  • Double-Blind Method
  • Female
  • Humans
  • Imipramine (therapeutic use)
  • Male
  • Middle Aged
  • Personality Inventory
  • Placebo Effect
  • Single-Blind Method

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: